Kaufman Rossin Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,300
Closed -$351K 142
2025
Q1
$351K Buy
+1,300
New +$351K 0.25% 71